Effect of in vivo produced fibrinogen-fibrin intermediates on viscosity of human blood.
D000328:Adult; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D000997:Antivenins / Q000494:pharmacology; D001780:Blood Coagulation Tests; D001799:Blood Sedimentation; D001809:Blood Viscosity; D002850:Chromatography, Gel; D005260:Female; D005337:Fibrin / Q000302:isolation & purification / Q000502:physiology*; D005340:Fibrinogen / Q000302:isolation & purification / Q000502:physiology*; D005947:Glucose / Q000008:administration & dosage; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000494:pharmacology; D012911:Snakes; D013997:Time Factors; D014688:Venoms
D000933:Antifibrinolytic Agents; D000997:Antivenins; D007457:Iodine Radioisotopes; D014688:Venoms; D005337:Fibrin; D005340:Fibrinogen; D010447:Peptide Hydrolases; D005947:Glucose